Design, synthesis and molecular modelling of novel methyl[4-oxo-2-(aroylimino)-3-(substituted phenyl)thiazolidin-5-ylidene]acetates as potent and selective aldose reductase inhibitors†
Abstract
A series of new iminothiazolidin-4-one acetate derivatives was synthesized and evaluated as